世界の医療用大麻市場の動向・成長・規模分析 製品形態別(粉末、固形、軟膏・クリーム、オイル、その他)、派生物別(カンナビジオール、テトラヒドロカンナビノール)、用途別(関節炎、がん、アルツハイマー病、その他)、流通チャネル別(薬局、オンラインストア、その他) - 2027年までの予測Global Medical Cannabis Market Trends, Growth and Size Analysis By Product form (Powders, Solids, Ointments and creams, Oil, Others), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Application (Arthritis, Cancer, Alzheimers Disease, Others) and By Distribution Channel (Retail pharmacy, Online stores, Others) Forecast to 2027 Global Medical Cannabis Market– Forecast to 2027 Market Snapshot As per the MRFR analysis, the global Medical Cannabis Market is expected to register a significant CAGR of 18.14% to surpass... もっと見る
サマリーGlobal Medical Cannabis Market– Forecast to 2027 Market Snapshot As per the MRFR analysis, the global Medical Cannabis Market is expected to register a significant CAGR of 18.14% to surpass USD 33,210.21 million by the end of 2027. Medical marijuana is also called cannabis that has viable remedial properties. The best thing about this plant is that it is used as an unrefined material by various medication associations to make drugs for various medicinal applications. The genuine usage of cannabis for clinical reasons is extending because of its compelling advantages. In any case, it shifts across countries due to the movement, proprietorship, advancement, and clinical finishes paperwork for its use. One more driver of the Medical Cannabis Market is the rising prevalence of continuous contaminations and different illnesses. Clinical Cannabis is ensured and amazing for additional creating signs, for instance, rest issues, pressure, and torture achieved by relentless infections in adults. The expansion of the Medical Cannabis Market is driven by various elements like augmentation in the usage of cannabis, a rising prevalence of progressing diseases, and considerably more. The growing legitimization of Medical Cannabis in different countries rises to research and improvement of cannabinoids. Nevertheless, growing unlawful usage of Maryjane is depended upon to check the overall Market Outlook advancement. There are various employments of cannabis in the clinical business, which is driving the Medical Cannabis Market development. In the current decade, the use of cannabis has extended even more immediately diverged from various substances. There has been a speedy advancement in cannabis use and is simply climbing in made countries like Western Europe, North America, and Australia. Segment Overview The global medical cannabis market is classified into Species, Derivatives, Application, End-use, and route of administration. Based on species, the market is divided into cannabis Indica, Sativa, and crossbreed. By derivatives segment, the market has been categorized into cannabidiol (CBD), tetrahydrocannabinol (THC), and much more. In terms of applications, the market has been divided into disease addresses the main classification. By end-use, the market has been classified into the drug business, innovative work communities, and much more. Depending on the route of administration, the market has been divided into oral arrangements and cases, smoking, vaporizers, topical, and others. Regional Analysis The Medical Cannabis market has been fragmented dependent on geographics, Asia-Pacific, Americas, Europe, the Middle East, and Africa. The Americas is depended upon to be the greatest market inferable from the rising consumption of clinical cannabis and rising per capita clinical consideration utilization. The market in the Americas has furthermore been stretched out into North America and Latin America, with the North American market divided into the US and Canada. The European Medical Cannabis market has been masterminded in Western Europe and Eastern Europe. Major Market Players The major players of the Medical Cannabis market include Canopy Growth, Corporation (Canada), GW Pharmaceuticals PLC (UK), Aurora Cannabis (Canada), Aphria, Inc. (Canada), Maricann Inc. (Canada), Tilray (Canada), Cannabis Sativa Inc. (US), GBSciences Inc. (US), United Cannabis (US), Medical Marijuana, Inc. (US), CanniMed Ltd (Canada), and MediPharm Labs (Canada) COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights. 目次目次1 エグゼクティブサマリー 2 市場の紹介 2.1 調査の範囲 2.2 研究目的 2.3 市場構造 2.4 仮定と限界 3 研究方法論 3.1 データマイニング 3.2 二次調査 3.3 一次調査 3.4 主要回答者の内訳 3.5 予測技術 3.6 市場規模推定のための調査方法 3.6.1 ボトムアップ・アプローチ 3.6.2 トップダウン・アプローチ 3.7 データの三角測量 3.8 バリデーション 4 マーケット・ダイナミクス 4.1 オーバービュー 4.2ドライバー 4.2.1 さまざまな民間および政府機関による研究開発活動と資金援助の拡大 4.2.2 慢性疾患やその他の病状の増加 4.2.3 様々な地域での医療用大麻の合法化 4.3つの休息方法 4.3.1 大麻に関連する有害作用 4.3.2 CBDオイルに関連する政府の厳格な政策 4.4つの機会 4.4.1 アジア・アフリカ諸国における大麻の地位向上 5 市場要因分析 5.1 バリューチェーン分析 5.1.1 原材料の調達 5.1.2 R&D 5.1.3製造 5.1.4 流通・販売 5.1.5 販売後のモニタリング 5.2 ポーターズファイブフォースモデル 5.2.1 サプライヤーのバーゲニングパワー 5.2.2 バイヤーのバーゲニング・パワー 5.2.3 新規参入者の脅威 5.2.4 代替品の脅威 5.2.5 ライバルの強さ 5.3 COVID-19の医療用大麻市場への影響 5.3.1 オーバービュー 5.3.2 サプライチェーンへの影響 5.3.3 医療用大麻の需要への影響 5.3.4 既存の規制への影響 5.3.5 研究への影響 5.3.6 バイヤーとサプライヤーへの影響 6 世界の医療用大麻市場:製品タイプ別 6.1 オーバービュー 6.2 SOLID 6.3 溶解物・粉体 6.4 OIL 6.5 軟膏・クリーム類 7 世界の医療用大麻市場:誘導体別 7.1 オーバービュー 7.2 カナビジョル(CANNABIDIOL 7.3 テトラヒドロカンナビノール 8 世界の医療用大麻市場:投与経路別 8.1 オーバービュー 8.2 吸入した場合 8.3 ORAL 8.4 トピカル 9 世界の医療用大麻市場:用途別 9.1 オーバービュー 9.2 疼痛管理 9.2.1 神経因性疼痛 9.2.2 癌 9.2.3 炎症性の痛み 9.3 神経学的健康管理 9.3.1 スクレロシス 9.3.2 エピレプシー 9.3.3 アルツハイマー型認知症 9.3.4 パーキンソン病 9.3.5 OTHERS 9.4 メンタルヘルスマネジメント 9.4.1 心的外傷後ストレス障害(PTSD) 9.4.2 DEPRESSION 9.4.3 アンキセチア 9.4.4 その他 10 世界の医療用大麻市場:流通チャネル別 10.1 オーバービュー 10.2 病院薬局 10.3 小売薬局 10.4 オンライン薬局 11 世界の医療用大麻市場:地域別 11.1 オーバービュー 11.2 アメリカ 11.2.1 北アメリカ 11.2.1.1 米国 11.2.1.2 CANADA 11.2.2 ラテンアメリカ 11.3 ヨーロッパ 11.3.1 西ヨーロッパ 11.3.1.1 ゲルマニウム 11.3.1.2 フランス 11.3.1.3 英国 11.3.1.4 イタリア 11.3.1.5 SPAIN 11.3.1.6 その他の西ヨーロッパ諸国 11.3.2 東欧 11.4 アジア・パシフィック 11.4.1 日本 11.4.2 オーストラリ ア 11.4.3 南朝鮮 11.4.4 その他のアジア・太平洋地域 11.5 中近東・アフリカ 11.5.1 中近東 11.5.2 アフリカ 12 競争状況 12.1 オーバービュー 12.2 競争力のあるベンチマーキング 12.3 世界の医療用大麻市場における主な成長戦略 12.4 世界の医療用大麻市場における開発数でのリーディングプレイヤー 12.5 キーディベロップメント分析 12.6 重要な開発と成長戦略 12.6.1 製品発売/製品承認 12.6.2 合併・買収 12.6.3 パートナーシップ/合意 12.6.4 エクスパンション 13社のプロフィール 13.1 キャノピー成長株式会社 13.1.1 会社概要 13.1.2 財務概要 13.1.3 提供する製品/サービス 13.1.4 主な進展 13.1.5 スウォット分析 13.1.6 主な戦略 13.2 カンナビス・サティバ, INC. 13.2.1 会社概要 13.2.2 財務概要 13.2.3 提供する製品/サービス 13.2.4 重要な進展 13.2.5 スウォット分析 13.2.6 主要戦略 13.3 GWファーマシューティカルズ・ピーエルシー 13.3.1 会社概要 13.3.2 財務概要 13.3.3 提供する製品/サービス 13.3.4 重要な進展 13.3.5 スウォット分析 13.3.6 主要戦略 13.4 エメラルド・ヘルス・セラピューティクス 13.4.1 会社概要 13.4.2 財務概要 13.4.3 提供する製品/サービス 13.4.4 重要な進展 13.4.5 スウォット分析 13.4.6 主要戦略 13.5 TILRAY, INC. 13.5.1 会社概要 13.5.2 財務概要 13.5.3 製品の提供 13.5.4 主な進展 13.5.5 スウォット分析 13.5.6 主要戦略 13.6 オーロラ・カンナビス社 13.6.1 会社概要 13.6.2 財務概要 13.6.3 提供する製品/サービス 13.6.4 主な進展 13.6.5 スウォット分析 13.6.6 主要戦略 13.7 カラ・セラピューティック 13.7.1 会社概要 13.7.2 財務概要 13.7.3 提供する製品/サービス 13.7.4 重要な進展 13.7.5 スウォット分析 13.7.6 主要戦略 13.8 メディカル・マリファナ, INC. 13.8.1 会社概要 13.8.2 財務概要 13.8.3 提供する製品/サービス 13.8.4 重要な進展 13.8.5 スウォット分析 13.8.6 主要戦略 13.9 ジービー・サイエンス・インク 13.9.1 会社概要 13.9.2 財務概要 13.9.3 提供する製品/サービス 13.9.4 重要な進展 13.9.5 スウォット分析 13.9.6 主要戦略 13.10 CANNDOC 13.10.1 会社概要 13.10.2 財務概要 13.10.3 提供する製品/サービス 13.10.4 重要な進展 13.10.5 スウォット分析 13.10.6 主要戦略 14 APPENDIX 14.1 参考文献 14.関連レポート2件
SummaryGlobal Medical Cannabis Market– Forecast to 2027 Market Snapshot As per the MRFR analysis, the global Medical Cannabis Market is expected to register a significant CAGR of 18.14% to surpass USD 33,210.21 million by the end of 2027. Medical marijuana is also called cannabis that has viable remedial properties. The best thing about this plant is that it is used as an unrefined material by various medication associations to make drugs for various medicinal applications. The genuine usage of cannabis for clinical reasons is extending because of its compelling advantages. In any case, it shifts across countries due to the movement, proprietorship, advancement, and clinical finishes paperwork for its use. One more driver of the Medical Cannabis Market is the rising prevalence of continuous contaminations and different illnesses. Clinical Cannabis is ensured and amazing for additional creating signs, for instance, rest issues, pressure, and torture achieved by relentless infections in adults. The expansion of the Medical Cannabis Market is driven by various elements like augmentation in the usage of cannabis, a rising prevalence of progressing diseases, and considerably more. The growing legitimization of Medical Cannabis in different countries rises to research and improvement of cannabinoids. Nevertheless, growing unlawful usage of Maryjane is depended upon to check the overall Market Outlook advancement. There are various employments of cannabis in the clinical business, which is driving the Medical Cannabis Market development. In the current decade, the use of cannabis has extended even more immediately diverged from various substances. There has been a speedy advancement in cannabis use and is simply climbing in made countries like Western Europe, North America, and Australia. Segment Overview The global medical cannabis market is classified into Species, Derivatives, Application, End-use, and route of administration. Based on species, the market is divided into cannabis Indica, Sativa, and crossbreed. By derivatives segment, the market has been categorized into cannabidiol (CBD), tetrahydrocannabinol (THC), and much more. In terms of applications, the market has been divided into disease addresses the main classification. By end-use, the market has been classified into the drug business, innovative work communities, and much more. Depending on the route of administration, the market has been divided into oral arrangements and cases, smoking, vaporizers, topical, and others. Regional Analysis The Medical Cannabis market has been fragmented dependent on geographics, Asia-Pacific, Americas, Europe, the Middle East, and Africa. The Americas is depended upon to be the greatest market inferable from the rising consumption of clinical cannabis and rising per capita clinical consideration utilization. The market in the Americas has furthermore been stretched out into North America and Latin America, with the North American market divided into the US and Canada. The European Medical Cannabis market has been masterminded in Western Europe and Eastern Europe. Major Market Players The major players of the Medical Cannabis market include Canopy Growth, Corporation (Canada), GW Pharmaceuticals PLC (UK), Aurora Cannabis (Canada), Aphria, Inc. (Canada), Maricann Inc. (Canada), Tilray (Canada), Cannabis Sativa Inc. (US), GBSciences Inc. (US), United Cannabis (US), Medical Marijuana, Inc. (US), CanniMed Ltd (Canada), and MediPharm Labs (Canada) COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights. Table of ContentsTABLE OF CONTENTS
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(通信回線)の最新刊レポート
Market Research Future社の通信回線分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Market Research Future社はどのような調査会社ですか?マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。 下記分野については、分野毎に専... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |